Citations

Showing 10 of 108162 citations.

Comparison of Preoperative Evaluation with the Pathological Report in Intraductal Papillary Mucinous Neoplasms: A Single-Center Experience
Grubor, Nikica , Micev, Marjan, Milić, Nataša , Knežević, Djordje , Gregorić, Pavle , Laušević, Željko, Kerkez, Mirko, Knĕzević, S, Radenković, Dejan , Milic, N , Djordjevic, Vladimir R. , Kovač, Jelena Djokić

Mayo Clinic

Journal of Clinical Medicine | February 12, 2021 | Volume: 10 | Issue: 4 | Pages: 678

10.3390/jcm10040678 | PMID 33578680 Get It

The key to the successful management of pancreatic cystic neoplasm (PCN), among which intraductal papillary mucinous neoplasm (IPMN) is the one with the highest risk of advanced neoplasia in resected patients, is a careful combination of clinical, radiological, and histopathological findings. This study aims to perform the comparison of a preoperative evaluation with pathological reports in IPMN and further, to evaluate and compare the diagnostic performance of European evidence-based guidelines on pancreatic cystic neoplasms (EEBGPCN) and Fukuoka Consensus guidelines (FCG). We analyzed 106 consecutive patients diagnosed with different types of PCN, among whom 68 had IPMN diagnosis, at the Clinical Center of Serbia. All the patients diagnosed with IPMNs were stratified concerning the presence of the absolute and relative indications according to EEBGPCN and high-risk stigmata and worrisome features according to FCG. Final histopathology revealed that IPMNs patients were further divided into malignant (50 patients) and benign (18 patients) groups, according to the pathological findings. The preoperative prediction of malignancy according to EEBGPCN criteria was higher than 70% with high sensitivity of at least one absolute or relative indication for resection. The diagnostic performance of FCG was shown as comparable to EEBGPCN. Nevertheless, the value of false-positive rate for surgical resection showed that in some cases, overtreating patients or treating them too early cannot be prevented. A multidisciplinary approach is essential to adequately select patients for the resection considering at the same time both the risks of surgery and malignancy.
Bland Embolization of Benign Liver Tumors: Review of the Literature and a Single Center Experience
Crawford, Daniel , Naidu, Sailen G., Patel, Indravadan , Knuttinen, Grace , Alzubaidi, Sadeer , Öklü, Rahmi , Naidu, Sailen, Oklu, Rahmi , Crawford, Daniel A , Naidu, Sailendra

Mayo Clinic

Journal of Clinical Medicine | February 12, 2021 | Volume: 10 | Issue: 4 | Pages: 658

10.3390/jcm10040658 | PMID 33572120 Get It

Transarterial embolization has shown promise as a safe, effective, and less invasive treatment modality for benign liver lesions (hemangioma, focal nodular hyperplasia (FNH), and hepatic adenoma (HA)) with fewer complications compared to surgical intervention. There is no consensus regarding the most appropriate embolization material(s) for the treatment of benign liver tumors. The purpose of this study was to review the current literature regarding the transarterial embolization of benign liver tumors and to share our single center experience. This was a non-blinded, retrospective, single-institution review of the bland embolization of benign liver tumors. Clinical data and imaging before and after embolization were used to evaluate lesion response to transarterial embolization. Twelve patients were included in the study. Five patients with six hemangiomas were treated. Pain was a presenting complaint in all five of these patients. The median change in tumor volume was −12.4% and ranged from −30.1% to +42.3%. One patient with two FNH lesions was treated, and both lesion volumes decreased by more than 50%. Six patients with 10 adenomas were treated. Pain was a presenting complaint in three patients, and five patients had a lesion >5 cm. The median change in tumor volume was −67.0% and ranged from −92.9% to +65.8%. Bland transarterial embolization of liver hemangiomas, FNH, and HA can be an effective and minimally invasive treatment modality to control the size and/or symptoms of these lesions. There is a variable response depending on tumor type and the embolization materials used.
Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach
Adjei, Araba A., Lopez, Camden , Schaid, Daniel J. , Sloan, Jeff A. , Le‐Rademacher, Jennifer , Loprinzi, Charles L. , Beutler, Andreas S. , Vachon, Celine M. , Ruddy, Kathryn J. , Lopez, Camden L , Le-Rademacher, Jennifer G , Norman, Aaron D. , Olson, Janet E. , Couch, Fergus J. , Vachon, Celine M.

Mayo Clinic

Cancers | February 12, 2021 | Volume: 13 | Issue: 4 | Pages: 716

10.3390/cancers13040716 | PMID 33578652 Get It

Health-related quality of life (HRQOL) is an important prognostic patient-reported outcome in oncology. Because prior studies suggest that HRQOL is, in part, heritable, we performed a GWAS to elucidate genetic factors associated with HRQOL in breast cancer survivors. Physical and mental HRQOL were measured via paper surveys that included the PROMIS-10 physical and mental health domain scales in 1442 breast cancer survivors participating in the Mayo Clinic Breast Disease Registry (MCBDR). In multivariable regression analyses, age and financial concerns were significantly associated with global physical health (age: p = 1.6 × 10−23; financial concerns: p = 4.8 × 10−40) and mental health (age: p = 3.5 × 10−7; financial concerns: p = 2.0 × 10−69). Chemotherapy was associated with worse global mental health (p = 0.01). In the GWAS, none of the SNPs reached the genome-wide association significance threshold of 5 × 10−8 for associations with either global physical or global mental health, however, a cluster of SNPs in SCN10A, particularly rs112718371, appeared to be linked to worse global physical health (p = 5.21 × 10−8). Additionally, SNPs in LMX1B, SGCD, PARP12 and SEMA5A were also moderately associated with worse physical and mental health (p < 10−6). These biologically plausible candidate SNPs warrant further study as possible predictors of HRQOL.
Patient Safety and Error Reduction in Surgical Pathology
Nakhleh, Raouf E.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 12, 2021 | Volume: 132 | Issue: 2 | Pages: 181-185

10.5858/2008-132-181-psaeri | PMID 18251572 Get It

Abstract Context.—National patient safety goals and error reduction efforts should be addressed by each surgical pathology laboratory. Objective.—To review issues relevant to patient safety and error reduction in surgical pathology in the context of continuous quality improvement. Data Sources.—The literature is reviewed. Conclusions.—Patient safety goals can and should be addressed within the context of a quality improvement plan. Multiple factors that contribute to errors in surgical pathology are discussed. The current literature defines the extent of these problems within specific segments of the test cycle (preanalytic, analytic, and postanalytic). Potential solutions are presented that may reduce or avoid errors. In addition, general principles are outlined that enhance the laboratory's ability to successfully and continuously address patient safety and error reduction.
Immunophenotypic Attributes of Benign Peripheral Blood γδ T Cells and Conditions Associated With Their Increase
Roden, Anja C. , Morice, William G. , Hanson, Curtis A. , Morice, William George

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 12, 2021 | Volume: 132 | Issue: 11 | Pages: 1774-1780

10.5858/132.11.1774 | PMID 18976014 Get It

Abstract Context. —In comparison to αβ T cells, little is known about the immunophenotype of healthy peripheral blood γδ T cells or about conditions associated with expansion of this usually minor T-cell subset. Objective. —To study the immunophenotype of increased nonneoplastic peripheral blood γδ T cells and to determine clinical conditions associated with this laboratory finding. Design. —Flow cytometric T-cell phenotyping studies performed on 352 consecutive peripheral blood specimens were reviewed, and 62 cases (18%) in which γδ T cells comprised either more than 5% of the total lymphocytes or had an absolute count of more than 200 cells per μL or both, were studied further. Clinical data were available from 36 cases. Results. —The γδ T cells often had an immunophenotype distinct from the αβ T cells, with differences in CD5 expression as the most common (n = 17), followed by differences in CD3 (n = 6) and CD7 (n = 3). CD16 coexpression by the γδ T cells was also frequent (n = 20). In 28 (78%) of 36 cases, there were one or more associated conditions: infection/inflammatory disease (n = 18), autoimmune disease (n = 9), lymphoproliferative disorder (n = 6), and splenectomy (n = 3). Conclusions. —Circulating γδ T cells are immunophenotypically distinct from αβ T cells, and mild increases in these cells are not uncommon and may be associated with immune system activation and splenectomy. Recognition of this phenomenon is important because reactive γδ T cells can exhibit distinctive immunophenotypic features that are also encountered in neoplastic conditions, such as T-cell large granular lymphocytic leukemia.
Physician Satisfaction With Surgical Pathology Reports: A 2-Year College of American Pathologists Q-Tracks Study
Nakhleh, Raouf E. , Souers, Rhona J., Ruby, Stephen G.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 132 | Issue: 11 | Pages: 1719-1722

10.5858/132.11.1719 | PMID 18976005 Get It

Abstract Context. —There are multiple elements that can be measured to assess the quality of a surgical pathology laboratory. Overall customer satisfaction is an excellent “global” measure, because it highlights the unique insight of laboratory performance from the users' perspective. Objective. —To measure customer satisfaction with surgical pathology reports. Design. —This study was based on a subscription Q-Tracks study. Voluntary participants were asked to distribute and collect a minimum of 25 surveys per quarter from their clients. Four parameters were graded, which included overall satisfaction, report turnaround time (TAT), completeness, and style on a scale of 1 (poor) to 5 (excellent). Each laboratory submitted quarterly data to the College of American Pathologists, where the data were tabulated and analyzed. Each laboratory could compare their performance in all 4 measures against the entire cohort or a selected subgroup of laboratories. Overall customer satisfaction with surgical pathology reports and 3 subcategories of report TAT, completeness, and style were the main outcome measures. Results. —This study ran during 2004 and 2005, with 41 and 33 participant laboratories, respectively. The median score for overall satisfaction, TAT, completeness, and style were 4.57, 4.31, 4.62, and 4.64 in 2004, and 4.64, 4.56, 4.65, and 4.68 in 2005, respectively. Most laboratories reported results for 4 quarters or fewer. There was no statistically significant change in overall satisfaction over time. Conclusions. —Overall satisfaction scores for surgical pathology reports as well as satisfaction with report TAT, completeness, and style were high. Report TAT received the lowest scores of all parameters.
ProEx C Immunocytochemistry and High-Risk Human Papillomavirus DNA Testing in Papanicolaou Tests With Atypical Squamous Cell (ASC-US) Cytology: Correlation Study With Histologic Biopsy
Hornaman, Kelly, Cohen, Cynthia , Siddiqui, Momin T. , Nassar, Aziza

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 132 | Issue: 10 | Pages: 1648-1652

10.5858/2008-132-1648-pciahh | PMID 18834224 Get It

Abstract Context. —Papanicolaou tests with atypical squamous cells of undetermined significance (ASC-US) cytology and adjunct testing for high-risk human papillomaviruses (hr-HPV) are helpful in detecting high-grade disease. Detection of disease may be further improved with molecular markers known to be overexpressed in cervical carcinoma. ProEx C detects 2 such molecular markers, minichromosome maintenance protein 2 and topoisomerase II, which are associated with abnormal cell cycle regulation. Objective. —To determine the utility of ProEx C as a marker for high-grade cervical intraepithelial neoplasia 2+ disease when compared with hr-HPV status in Papanicolaou tests with ASC-US cytology. Design. —A SurePath slide was prepared on all ASC-US cases from the residual SurePath vial pellet and stained using the ProEx C reagent prediluted with water-bath antigen retrieval, using a Dako autostainer. Nuclear staining of cytologically atypical squamous cells was considered a positive result. Adjunct testing for hr-HPV used Digene Hybrid Capture 2. Follow-up biopsy results were available for review following the Papanicolaou test. Results. —Two hundred patients with ASC-US diagnoses were part of this study. The sensitivities of ProEx C and hr-HPV testing in detecting high-grade cervical intraepithelial neoplasia 2+ disease were 98.04% and 82.35%, respectively, whereas the specificity for detecting high-grade disease was 74.50% and 73.15%, respectively. Conclusions. —ProEx C staining is a more sensitive and specific biomarker for detecting cervical disease than adjunct testing for hr-HPV status in Papanicolaou tests with ASC-US.
Comparison of Primary and Metastatic Malignant Melanoma of the Esophagus: Clinicopathologic Review of 10 Cases
Sanchez, Amy A., Wu, Tsung Teh, Prieto, Víctor G. , Rashid, Asif , Hamilton, Stanley R. , Wang, Huamin

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 132 | Issue: 10 | Pages: 1623-1629

10.5858/2008-132-1623-copamm | PMID 18834221 Get It

Abstract Context. —Primary esophageal melanoma (PEM) is a rare disease and is difficult to distinguish from other esophageal malignancies and from metastatic melanoma. Objective. —To develop diagnostic criteria for PEM, we compared the clinicopathologic features of 5 PEMs and 5 metastatic melanomas to esophagus. Design. —Ten cases of esophageal melanoma, including 4 surgically resected specimens, 2 autopsy cases, and 4 cases reported on mucosal biopsies, were reviewed. The histologic parameters used in this study were well-characterized features for cutaneous melanoma, including junctional component (in situ melanoma), radial growth phase, modified Breslow thickness, depth of invasion, lymphovascular invasion, satellitosis, predominant type of cytology, and regional lymph node metastasis. Clinical and follow-up information was obtained by reviewing patients' medical records. Results. —Previous history of cutaneous melanoma was present in all 5 cases of metastatic esophageal melanoma but was not present in the 5 patients with PEMs. In situ melanoma and/or radial growth phase were identified in all 5 PEMs but were not present in any of the metastatic cases. Among the 4 resected and 2 autopsy cases, melanocytosis and mixed epithelioid and spindle cell morphology was present in 2 (50%) of 4 PEMs but was not present in 2 (40%) of the metastatic melanomas. Melanin pigment was detectable in all cases. Patients with PEM had better survival than those who had metastatic melanoma to esophagus ( P = .03). Conclusions. —The presence of in situ melanoma, radial growth phase, melanocytosis, and mixed epithelioid and spindle cell morphology, in the context of no history of melanoma, distinguishes PEM from metastatic melanoma.
PO2RDF: Representation of Real-world Data for Precision Oncology Using Resource Description Framework
Zhao, Yiqing , Shen, Feichen , Zong, Nansu , Wang, Chen , Wang, Chen , Dimou, Anastasios, Davila, Jaime , Liu, Hongfang

Mayo Clinic

No container title available | February 11, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-219654/v1 Get It

Abstract Background: Next-generation sequencing provides comprehensive information about individuals’ genetic makeup and is commonplace in precision oncology practice. Due to the heterogeneity of individual patient’s disease conditions and treatment journeys, not all targeted therapies were initiated despite actionable mutations. To better understand and support the clinical decision-making process in precision oncology, there is a need to examine real-world associations of patients’ genetic information and treatment choice.Methods: To fill the gap of insufficient use of real-world data (RWD) in electronic health records (EHRs), we generated a single Resource Description Framework (RDF) resource, called PO2RDF (precision oncology to RDF) by integrating information regarding gene, variant, disease, and drug from genetic reports and EHRs. Results: There are total 2,309,014 triples contained in the PO2RDF. Among them 32,815 triples are related to Gene, 34,695 triples are related to Variant, 8,787 triples are related to Disease, 26,154 triples are related to Drug. We performed one use case analysis to demonstrate the usability of the PO2RDF: we examined real-world associations between EGFR mutations and targeted therapies to confirm existing knowledge and detect off-label use. Conclusions: In conclusion, our work proposed to use RDF to organize and distribute clinical RWD that is otherwise inaccessible externally. Our work serves as a pilot study that will lead to new clinical applications and could ultimately stimulate progress in the field of precision oncology.
Glial Fibrillary Acidic Protein and CD57 Immunolocalization in Cell Block Preparations Is a Useful Adjunct in the Diagnosis of Pleomorphic Adenoma
Shah, Sejal , Chandan, Vishal S. , Wilbur, David C. , Khurana, Kamal K.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 9 | Pages: 1373-1377

10.5858/2007-131-1373-gfapac | PMID 17824792 Get It

Abstract Context. —The cytologic distinction between pleomorphic adenoma (PA) and adenoid cystic carcinoma (ACC) can be diagnostically challenging in aspirate smears. Hence a cytologic diagnosis of “atypical cytology” with a differential diagnosis including PA and ACC is occasionally rendered in a subset of salivary gland fine-needle aspirations. Objective. —To evaluate the role of glial fibrillary acidic protein (GFAP) and CD57 expression in cell block material obtained during fine-needle aspiration procedure in differentiating PA from ACC. Design. —We performed GFAP and CD57 immunostains on formalin-fixed, paraffin-embedded cell block sections of 26 salivary gland fine-needle aspiration cases with the following cytologic diagnoses: (1) PA (10 cases); (2) atypical cytology, cannot exclude ACC (8 cases); and (3) ACC (8 cases). Results. —All 10 (100%) cases with cytologic diagnoses of PA were positive for GFAP, and 8 (80%) of 10 cases were positive for CD57; tissue follow-up confirmed the diagnosis of PA in all cases. All 8 (100%) cases with cytologic diagnosis of ACC were negative for both GFAP and CD57; tissue follow-up confirmed the diagnoses of ACC in all cases. Of the 8 cases with diagnoses of atypical cytology, 4 (50%) were negative and 4 (50%) were positive for both GFAP and CD57. Subsequent tissue follow-up in these cases revealed 4 cases of ACC (all negative for GFAP and CD57) and 4 cases of PA (all positive for GFAP and CD57). Conclusions. —Our results show that positive staining for GFAP and CD57 serves as a useful adjunct for the diagnosis of PA and helps to reduce the uncertainty in challenging cases.